Intrapleural fibrinolytic treatment of empyemas Source: Eur Respir J 2005; 26: Suppl. 49, 491s Year: 2005
Intrapleural urokinase in the management of empyema in children Source: Eur Respir J 2004; 24: Suppl. 48, 620s Year: 2004
Ten years experience of use of intrapleural streptokinase (IPSK) for empyema Source: Eur Respir J 2001; 18: Suppl. 33, 319s Year: 2001
Intrapleural instillation of fibrinolytics in the treatment complicated pneumonia in children. Case study Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002
A clinical comparison of intrapleural heparin versus urokinase in the management of tuberculous pleurisy Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
Intrapleural streptokinase treatment of complicated parapneumonic effusions and empyemas Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013
Respiratory functional status after intrapleural t-PA administration for complicated parapneumonic effusions Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012
Intrapleural use of dornase alfa and tissue plasminogen activator are successful as treatment in pediatric empyema: a pilot study Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018
The effect of intrapleural fibrinolytic therapy in the drainage of loculated haemorrhagic effusions Source: Eur Respir J 2001; 18: Suppl. 33, 387s Year: 2001
Efficacy of thrombolytic agents in the treatment of pulmonary embolism Source: Eur Respir J 2005; 26: 864-874 Year: 2005
Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema Source: Annual Congress 2008 - Pleural effusion Year: 2008
Intrapleural streptokinase for empyema thoracis in childhood Source: ISSN=ISSN 1810-6838, ISBN=, page=154 Year: 2004
Intrapleural streptokinase in the management of loculated pleural fluids of various aetiologies Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Outcomes of Fibrinolytic therapy for acute empyema. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Intrapleural streptokinase for empyema and complicated parapneumonic effusions: a randomised controlled trial Source: Annual Congress 2004 - New diagnostic and therapeutic applications in bronchoscopy and thoracoscopy Year: 2004
Variable adoption of intrapleural fibrinolytic therapy for pleural space infections Source: International Congress 2018 – Pleural interventions Year: 2018
Pneumothorax and urokinase for pleural empyema in children Source: Eur Respir J 2001; 18: Suppl. 33, 170s Year: 2001
Intrapleural interleukin 2 in the treatment of persistent pneumothorax in patients not eligible for surgery Source: Eur Respir J 2007; 30: Suppl. 51, 105s Year: 2007
Use of intrapleural streptokinase and alteplase vs CTT alone in the resolution ofloculated pleural effusion among adult patients Source: International Congress 2019 – Clinical problems Year: 2019
Fibrinolysis with tenecteplase in the management of massive pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004